AYUSH – GCP Dr Sathiya Rajeswaran Research Officer SCRI,CCRS,Chennai All roads meet a common goal Roads are different goal is same • ICMR • WHO. ‘Good Clinical Practice Guidelines’ published by AYUSH Ministry for clinical trials of Ayurveda, Siddha & Unani drugs. There are four Research. The department of Ayush has issued good clinical practice (GCP) guidelines for clinical trials in Ayurveda, Siddha and Unani (ASU) medicines.
||Health and Food
||1 March 2016
|PDF File Size:
|ePub File Size:
||Free* [*Free Regsitration Required]
AYUSH GCP GUIDELINES | CENTRALCOUNCILFORRESEARCHINSIDDHA PUBLICATIONS –
The guidelines are significant as although the ASU systems are known for their long history of safe and effective use, yet validation of safety and efficacy using scientific and evidence-based methodologies is needed for the purpose of universal acceptability, gaining confidence of practitioners and satisfaction of end users in the products.
The case of Ayurveda, however, is different as the treatment regimen is already in use. Eur J Clin Invest.
However, the proposed guidelines seem to have been drawn up on the basis of Western biomedical approaches, including randomized controlled trials, as necessary evidence. EGLN1 involvement in high-altitude adaptation revealed through genetic analysis of extreme constitution types defined in Ayurveda.
Regulation on AYUSH system of Good Clinical Practice Guidelines
The department of Ayush has issued good clinical practice GCP guidelines for clinical trials ayyush Ayurveda, Siddha and Unani ASU medicines which will facilitate the researchers and institutions in adopting a standard way of good clinical practice while conducting the ASU clinical trials. However, it still needs safe and effective options on a fast track.
Enter the email address you signed up with and we’ll email you a reset link. National Center for Biotechnology InformationU. Type 1 error minimizes the chances of releasing a bad drug into the market and power maximizes the chance of discovering a good drug.
Apr 22, 6: J Ayurveda Gccp Med. Equipoise and the Dilemma of Randomized Clinical Trials. Phase I trials should preferably be carried out with access to the necessary facilities to closely observe and monitor the Subjects.
The guidelines are addressed to investigators and all those, who are interested, concerned, involved and affected with the conduct of clinical trials on ASU drugs. Researchers, sponsors and drug manufacturers, therefore, have to be well versed with the standard scientific procedures that are required to be followed while conducting clinical gudielines with ASU interventions to achieve objective and reproducible results.
The black box approach, pragmatic trials, and the whole system approach of Ayurveda needs to be maintained rather than accepting reductionist methods of treating any symptom or disease condition in isolation. Int J Ayurveda Res. Performing clinical trials and producing the proof on the basis of these guidelines would help believe the world about the prospective scale of ASU remedies in scientific jargon and tackle the questions of lack of facts and substantiation.
Transparency implies a factual reporting of everything that was done in the planning and conducting of the specific clinical research. Miller FG, Joffe S. Miller and Joffe’s criteria may be generalized to Ayurvedic treatments.
Ayurvedic Genomics – Establishing a genetic basis for mind body typologies.
This article has been cited by other articles in PMC. However, blinding of the outcomes to the evaluators can ensure an unbiased comparison.
Regulation on AYUSH system of Good Clinical Practice Guidelines | Business Standard News
J Ayurveda Integrat Med. The Standard manufacturing practices and a well laid system of technical documentation of safety of products are two fundamental necessities of ISM sector was prominently missing for guidrlines long time. Gcl ancestral and present populations receiving traditional treatments provide better clinical assessment than carefully selected members of some contemporary RCT.
The Case Record Form should be in such a form and format that allows accurate input, presentation, verification, audit and inspection of the recorded data. Apr 19, 1: Your email address will not be published. Typically, Ayurveda treatments should not need Phase 4 trials.
The proposed ASU guidelines are expected to generate a body of clinical research based on bioethics, transparency in reporting, and lack of scientific bias. It is noteworthy that the outcomes of the pilot whole system study comparing the classical Ayurvedic treatment and methotrexate in the management of RA, with funding from National Institutes of Health, has been recently published by Annals of Rheumatic Disease.
I would like to join. Such Indianized, innovative guidelines on GCP for ASU would not only give due respect, leadership, and a major boost to this sector, but also offer freedom from the over-dominance of RCTs. The fourth criterion requires a historical control group.
A noxious and unintended response at doses normally used or tested in humans b In case of new unregistered ASU Medicines: The objective of this page log document is to encourage that clinical studies in ASU systems are undertaken in accordance with ethical and scientific standards and safety aspects and rights of participants are protected.
In other words acknowledging the shortcomings of any trial and transparency in reporting greatly enhances the value of the trial. If we attempt to do so, the global scientific community should also benefit, where the relevance of RCTs in the light of integrative medicine has already been greatly debated for better alternatives. Understanding the underlying Ayurvedic biology, physiology, pathology, pathways, and mechanisms through which treatments exercise their benefits is far more important.